2026 ICD-10-CM Diagnosis Code T37.8X1APoisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter

ICD-10-CM CodesS00–T88T36-T50T37

ICD-10-CM T37.8X1A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T37.8X1A is a billable ICD-10-CM diagnosis code for poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, accidental/unintentional; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.

Code Identity

ICD-10-CM Code
T37.8X1A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter
Short Description
Poisoning by oth systemic anti-infect/parasit, acc, init
Parent Code
Poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT37Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics
This CodeT37.8X1APoisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental diiodohydroxyquinoline poisoning
  • Accidental flucytosine overdose
  • Accidental flucytosine poisoning
  • Accidental hydroxyquinoline overdose
  • Accidental hydroxyquinoline poisoning
  • Accidental sulfamethoxazole and/or trimethoprim overdose
  • Accidental sulfamethoxazole and/or trimethoprim poisoning
  • Accidental trimethoprim overdose
  • Accidental trimethoprim poisoning
  • Flucytosine overdose
  • Hydroxyquinoline overdose
  • Hydroxyquinoline poisoning
  • Nitrofuran derivative overdose
  • Poisoning by chiniofon
  • Poisoning by diiodohydroxyquin
  • Poisoning by flucytosine
  • Poisoning by nitrofuran derivatives
  • Poisoning caused by quinoline
  • Sulfamethoxazole and/or trimethoprim overdose
  • Trimethoprim overdose
  • Trimethoprim poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of other systemic anti-infectives and antiparasitics (T37). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT020
External cause codes: intent of injury, accidental/unintentional
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Bithionol

    halogenated anti-infective agent that is used against trematode and cestode infestations.
  • Cinoxacin

    synthetic antimicrobial related to oxolinic acid and nalidixic acid and used in urinary tract infections.
  • Clioquinol

    a potentially neurotoxic 8-hydroxyquinoline derivative long used as a topical anti-infective, intestinal antiamebic, and vaginal trichomonacide. the oral preparation has been shown to cause subacute myelo-optic neuropathy and has been banned worldwide.
  • Fluconazole

    triazole antifungal agent that is used to treat oropharyngeal candidiasis and cryptococcal meningitis in aids.
  • Flucytosine

    a fluorinated cytosine analog that is used as an antifungal agent.
  • Furazolidone

    a nitrofuran derivative with antiprotozoal and antibacterial activity. furazolidone acts by gradual inhibition of monoamine oxidase. (from martindale, the extra pharmacopoeia, 30th ed, p514)
  • Hexetidine

    a bactericidal and fungicidal antiseptic. it is used as a 0.1% mouthwash for local infections and oral hygiene. (from martindale, the extra pharmacopoeia, 30th ed, p797)
  • Hydroxychloroquine

    a chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. it inhibits plasmodial heme polymerase. (from gilman et al., goodman and gilman's the pharmacological basis of therapeutics, 9th ed, p970)
  • Iodoquinol

    one of the halogenated 8-quinolinols widely used as an intestinal antiseptic, especially as an antiamebic agent. it is also used topically in other infections and may cause cns and eye damage. it is known by very many similar trade names world-wide.
  • Itraconazole

    a triazole antifungal agent that inhibits cytochrome p-450-dependent enzymes required for ergosterol synthesis.
  • Diatrizoate Meglumine

    a versatile contrast medium used for diagnostic x-ray radiology.
  • Iothalamate Meglumine

    a radiopaque medium used for urography, angiography, venography, and myelography. it is highly viscous and binds to plasma proteins.
  • Ioxaglic Acid

    a low-osmolar, ionic contrast medium used in various radiographic procedures.
  • Meglumine

    1-deoxy-1-(methylamino)-d-glucitol. a derivative of sorbitol in which the hydroxyl group in position 1 is replaced by a methylamino group. often used in conjunction with iodinated organic compounds as contrast medium.
  • Meglumine Antimoniate

    antimony salt of meglumine that is used in the treatment of leishmaniasis.
  • Metronidazole

    a nitroimidazole used to treat amebiasis; vaginitis; trichomonas infections; giardiasis; anaerobic bacteria; and treponemal infections.
  • Nalidixic Acid

    a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. it is an inhibitor of the a subunit of bacterial dna gyrase.
  • Nifuratel

    local antiprotozoal and antifungal agent that may also be given orally.
  • Nitrofurantoin

    a urinary anti-infective agent effective against most gram-positive and gram-negative organisms. although sulfonamides and antibiotics are usually the agents of choice for urinary tract infections, nitrofurantoin is widely used for prophylaxis and long-term suppression.
  • Oxolinic Acid

    synthetic antimicrobial related to nalidixic acid and used in urinary tract infections.
  • Pefloxacin

    a synthetic broad-spectrum fluoroquinolone antibacterial agent active against most gram-negative and gram-positive bacteria.
  • Pipemidic Acid

    antimicrobial against gram negative and some gram positive bacteria. it is protein bound and concentrated in bile and urine and used for gastrointestinal, biliary, and urinary infections.
  • Piromidic Acid

    antibacterial against mainly gram negative organisms. it is used for urinary tract and intestinal infections.
  • Trimethoprim

    a pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to pyrimethamine. it is potentiated by sulfonamides and the trimethoprim, sulfamethoxazole drug combination is the form most often used. it is sometimes used alone as an antimalarial. trimethoprim resistance has been reported.
  • Trimethoprim Resistance

    nonsusceptibility of bacteria to the action of trimethoprim.
  • Trimethoprim, Sulfamethoxazole Drug Combination

    a drug combination with broad-spectrum antibacterial activity against both gram-positive and gram-negative organisms. it is effective in the treatment of many infections, including pneumocystis pneumonia in aids.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AkritoinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Arsphenamine (silver)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
BismarsenT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
BithionolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Bithionol::anthelminticT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
BroxyquinolineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
ChiniofonT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
CinoxacinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
ClioquinolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
CroconazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
DichlorhydroxyquinolineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
DiiodohydroxyquinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Diiodohydroxyquin::topicalT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
DiiodohydroxyquinolineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
DiodoquinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FloraquinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FluconazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FlucytosineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FlumequineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FlunidazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FluorocytosineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
FurazolidoneT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Hexamine (mandelate)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
HexetidineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
HydroxychloroquineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Hydroxyquinoline (derivatives) NECT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
IodobismitolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
IodochlorhydroxyquinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Iodochlorhydroxyquin::topicalT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
IodochlorhydroxyquinolineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
IodoquinolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
ItraconazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Mandelic acidT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
MapharsenT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
MeglumineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Meglumine::antimoniateT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Meglumine::diatrizoateT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Meglumine::iodipamideT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Meglumine::iotroxateT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Methenamine (mandelate)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
MetronidazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Nalidixic acidT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NeoarsphenamineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NeosalvarsanT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NeosilversalvarsanT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NifuratelT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NifurtoinolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NitrofurantoinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
NitroxolineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Oxolinic acidT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Oxyquinoline (derivatives)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
PefloxacinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Pipemidic acidT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Piromidic acidT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
QuiniobineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Quinoline (derivatives) NECT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
RosoxacinT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Salvarsan 606 (neosilver) (silver)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
StovarsalT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
SulfarsphenamineT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Tartar emeticT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Tartrated antimony (anti-infective)T37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
ThiobismolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
ThiocarbarsoneT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
TrimethoprimT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Trimethoprim::with sulfamethoxazoleT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Urinary anti-infectiveT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
VioformT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
Vioform::topicalT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6
XibornolT37.8X1T37.8X2T37.8X3T37.8X4T37.8X5T37.8X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T37.8X1A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
961.9 Pois-anti-infect NEC/NOS
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E857 Acc pois-oth anti-infect
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T37.8X1AOverview

Is T37.8X1A a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T37.8X1A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), such as an emergency visit or first evaluation.

What MS-DRG does T37.8X1A group to?

When poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of T37.8X1A?

Under the General Equivalence Mappings, poisoning by other specified systemic anti-infectives and antiparasitics, accidental (unintentional), initial encounter converts to ICD-9-CM 961.9 (pois-anti-infect NEC/NOS) and E857 (acc pois-oth anti-infect). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.